EAP for 5613 patients with relapsed/refractory acute leukemias with genetic alterations w/ HOXA
Clinical Trial Grant
Administered By
Pediatrics, Transplant and Cellular Therapy
Awarded By
Syndax Pharmaceuticals Inc
Start Date
July 30, 2024
End Date
May 28, 2026
Administered By
Pediatrics, Transplant and Cellular Therapy
Awarded By
Syndax Pharmaceuticals Inc
Start Date
July 30, 2024
End Date
May 28, 2026